(Q36096407)

English

Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Administration of Fozivudine tidoxil as a single-agent therapeutic during acute feline immunodeficiency virus infection does not alter chronic infection (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

feline immunodeficiency virus

object named as

feline immunodeficiency virus

1 reference

based on heuristic

inferred from title

author name string

Michelle M Miller

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Jonathan E Fogle

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

publication date

7 June 2012

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

954-962

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

copyright license

Creative Commons Attribution 4.0 International

7 June 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Antiviral therapy reduces viral burden but does not prevent thymic involution in young cats infected with feline immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 October 2017

Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 July 2018

Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

2 July 2018

Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection.

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Development of clinical disease in cats experimentally infected with feline immunodeficiency virus

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

CD4+CD25+ regulatory T cells are infected and activated during acute FIV infection

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3397356

23 September 2018

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.3390%2FV4060954

21 January 2018

Biological and virologic characteristics of primary HIV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/22816034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II placebo-controlled trial of fozivudine tidoxil for HIV infection: pharmacokinetics, tolerability, and efficacy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22816034

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3390/V4060954

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36096407&oldid=2013403929"